Junhee Yoon

Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.

S. Tomlins, S. Kaffenberger, T. Morgan, 2019, JCO precision oncology.

LOSS OF THE TUMOR SUPPRESSOR, TP53, ENHANCES THE ANDROGEN RECEPTOR MEDIATED ONCOGENIC TRANSFORMATION AND TUMOR DEVELOPMENT IN THE MOUSE PROSTATE

R. Cardiff, Zijie Sun, J. Geradts, 2019, Oncogene.

Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential

M. Freeman, B. Knudsen, I. Garraway, 2020, BMC Cancer.

A comparative study of PCS and PAM50 prostate cancer classification schemes

B. Trock, E. Klein, S. Freedland, 2021, Prostate Cancer and Prostatic Diseases.

Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.

Emily Y. Ko, Alka A. Potdar, D. Underhill, 2021, Cancer cell.

27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells

J. Turkson, S. Freedland, J. Chi, 2020, Molecular Cancer Research.

A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

H. Tseng, F. Feng, M. Freeman, 2019, Theranostics.

Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target.

Jayoung Kim, K. Kim, S. You, 2018, Cancer letters.